Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 294

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 294
---
 to forfeit all 4,177,778of its Private Placement Warrants to purchase shares of the Company’s Class A common stock, exercisable at $ 11.50per share (the “Forfeited Private Placement Warrants”), acquired by the Sponsor in March 2021 in connection with the Initial Public Offering. Upon the closing of the Business Combination, the Sponsor forfeited 4,177,778private warrants, while the 835,555private warrants issued to Cantor were converted into a right to purchase shares of the combined company’s Common Stock. In addition, pursuant to the terms of the Business Combination Agreement, 6,900,000public warrants were converted into a right to purchase the combined company’s Common Stock. Note 5. Related Party Transactions Founder Shares In December 2020, the Sponsor paid $ 25,000, or approximately $ 0.004per share, to cover certain offering costs in consideration for 5,750,000Class B common stock, par value $ 0.0001(the “Founder Shares”). In February 2021, the Company effected a stock dividend of 0.2shares for each share of Class B common stock outstanding, resulting in the Sponsor holding an aggregate of 6,900,000Founder Shares (up to an aggregate of 900,000of which were subject to forfeiture depending on the extent to which the underwriters’ over-allotment option is exercised). As a result of the underwriters’ election to fully exercise their over-allotment option, the 900,000shares were no longer subject to forfeiture. On September 20, 2023, the Sponsor converted all of its Class B common stock on a one-for-one basis into Class A common stock. The Sponsor will not have any redemption rights in connection with the Converted Shares, and the Converted Shares will be subject to the restrictions on transfer entered into by the Sponsor in connection with the IPO. The Sponsor has agreed not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one yearafter the completion of the initial Business Combination and (B) the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction after the initial Business Combination that results in all of its stockholders having the right to exchange their Class A common stock for cash, securities or other property (the “lock-up”). Notwithstanding the foregoing, if the closing price of the Company’s Class A common stock equals or exceeds $